Cucurbitacin E (CucE), a triterpenoid isolated from Cucurbitaceae plants, has been shown to possess an anti-inflammatory or immunosuppressive activity in vitro and in vivo, yet the underlying mechanism has been incompletely understood. The aim of the present study was to explore its effect on cytokine expression and the underlying mechanism in human Jurkat T cells as a cellular model. The results showed that CucE significantly inhibited the production of interleukin-2, tumor necrosis factor-α, and interferon-γ in culture medium of cells treated with phorbol 12,13-dibutyrate (PDB) plus ionomycin (Ion). Furthermore, the mRNA levels of these cytokines in activated Jurkat T cells were also decreased upon CucE treatment, suggesting a potential modulatory effect on the critical signaling pathways for cytokine expression, including nuclear factor-κB (NF-κB) or mitogen-activated protein kinases (MAPKs). In support of its effect on the NF-κB signaling pathway, CucE decreased the phosphorylation levels of inhibitor of κB (IκB) and NF-κB/p65 in PDB + Ion-stimulated cells. Further supporting this, the nuclear translocation of NF-κB/p65 was significantly suppressed in response to PDB plus Ion stimulation in the presence of CucE. The phosphorylation of p38MAPK, c-Jun N-terminal kinase (JNK), and Erk1/2, however, was not decreased or slightly increased at some time points by CucE treatment. Collectively, these data suggest that CucE may exhibit immunosuppressive effect by attenuating critical cytokine expression through down-regulating the NF-κB signaling pathway.
Introduction
Cucurbitacins are a group of tetracyclic triterpenes isolated from Cucurbitaceae plants, and they possess a wide spectrum of pharmacological properties including anticancer, anti-diabetic, cytoprotective, and anti-inflammatory activities [1] [2] [3] . Cucurbitacin E (CucE), one of the abundant members of the cucurbitacin family, has similar pharmacological activities to other cucurbitacins [3, 4] . The anticancer activity of CucE has been proposed to be mediated by inhibiting signal transducer and activator of transcription 3 phosphorylation in cancer cells [5] . Recent studies showed that CucE, like other cucurbitacins [6, 7] , disrupts the actin cytoskeleton in cells leading to cell cycle arrest at G 2 /M phases [3, 8, 9] , suggesting that actin is one of the potential targets for these compounds. It has been found that activation of cofilin by cucurbitacins may be an important event in damaging the actin cytoskeleton [10] [11] [12] [13] . Beyond its anticancer activity, CucE has received much attention for its anti-inflammatory activity as revealed by both in vitro and in vivo models. Such effects of CucE may be mediated by suppressing the expression of cyclooxygenase-2 and the production of nitric oxide as well as by inhibiting tumor necrosis factor (TNF)-α and interleukin (IL)-1β expression in innate immune cells [3, 14] . However, the immune modulatory effect of CucE on the adaptive immune cells, particularly T cells, is largely unknown.
T cells play a central role in both the innate and the adaptive immunity. Upon activation, T cells produce a variety of cytokines including IL-2, TNF-α, and interferon (IFN)-γ, which not only affect the proliferation and functions of themselves but also act on other immune cells to modulate their responses [15, 16] . The transcription of these cytokine genes is controlled by several critical signaling pathways including the nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways [16, 17] . These signaling cascades are involved in T cell activation and cytokine expression and have been investigated as targets for immunomodulatory or immunosuppressive agents [16, 17] . Thus, it is of interest to explore the effect of CucE on the responses of T cells upon mitogen stimulation.
The aim of this study was to explore the immunosuppressive effect of CucE and its action mechanism in human Jurkat T cells, which is a useful cellular model for evaluating T cell functions. Our data suggested that CucE could significantly suppress cytokine expression in Jurkat T cells via down-regulating the NF-κB signaling, highlighting its potential action on the adaptive immune response.
Materials and Methods

Reagents
CucE ( purity: 98.0%) was obtained from Shanghai Shunbo Bioengineering Technology Co. (Shanghai, China), and dissolved in dimethyl sulfoxide (DMSO) at 10 mM and stored at −20°C. Diluted working solution was prepared freshly before each experiment, and the final concentration of DMSO was <0.2%. Phorbol 12,13-dibutyrate (PDB), ionomycin (Ion), paraformaldehyde, and DMSO were purchased from Sigma-Aldrich (St Louis, USA). RPMI-1640, fetal bovine serum (FBS), 2-mercaptoethanol, L-glutamine, penicillin, streptomycin, and Trizol reagent were obtained from Invitrogen (Carlsbad, USA). WST-1 assay kit was obtained from Roche (Penzberg, Germany). The primary antibodies for western blotting were purchased from Cell Signaling Technology (Danvers, USA). Human Th1/Th2/Th17 cytometric bead array kits used to measure IL-2, TNF-α, and IFN-γ were obtained from BD Biosciences (San Jose, USA).
Cell culture
Jurkat T cells were obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China) and cultured in RPMI-1640 medium supplemented with 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin. Cells were cultured at 37°C with 5% CO 2 in a humidified atmosphere and subcultured every 2-3 days.
Cytotoxicity assay
Cells in log-phase were seeded in 96-well plates (1 × 10 4 cells/well) and treated with different concentrations of CucE alone or treated with PDB (0.5 μM) + Ion (0.5 μg/ml) in the presence or absence of graded doses of CucE, respectively. The working concentration of DMSO never exceeded 0.2%, which was shown to be non-cytotoxic in Jurkat cells (data not shown). An amount of 10 μl of WST-1 reagent was added to each well after 6 and 24 h, respectively, and the plates were incubated for <4 h at 37°C. Relative proliferation was quantified by measuring the absorbance at 450 nm with a reference at 630 nm using a microplate reader (model 680; Bio-Rad; Hercules, USA).
Determination of soluble cytokines
Cells were stimulated with PDB (0.5 μM) + Ion (0.5 μg/ml) in the presence or absence of graded doses of CucE. Soluble cytokine proteins in culture medium were quantitatively measured by cytometric bead array kit according to the manufacturer's instructions. Data were acquired using CELLQuest software on a flow cytometer (FACSCalibur).
Relative quantitative RT-PCR
Total RNA samples were isolated from Jurkat T cells using Trizol reagent according to the manufacturer's instructions. The total RNA products were immediately transcribed into cDNA using a PrimeScript RT reagent kit with gDNA eraser (TaKaRa, Dalian, China). The primers used are as follows: 5′-TGAAGGACGAGGAGTACGAGC-3′ (sense) and 5′-TGCAGGAACGAGTCTCCGT-3′ (anti-sense) for IL-2; 5′-CGTGGAACTGGCAGAAGAG-3′ (sense) and 5′-TGAGAA GAGGCTGAGACATAGG-3′ (anti-sense) for TNF-α; 5′-AGATCTG GCACCACACCTTCT-3′ (sense) and 5′-CTTTGATGTCACGCAC GATTT-3′ (anti-sense) for IFN-γ; 5′-TGGTACCACCATGTACCC AG-3′ (sense) and 5′-AAGGGTGTAAAACGCAGCTC-3′ (anti-sense) for β-Actin. PCR amplification was performed in a Chromo4 FourColor Real-Time PCR Detection System (Bio-Rad) using the SYBR Premix Ex TaqII (Tli RNaseH Plus) kit (TaKaRa). The specificity of PCR was determined by a following melting curve analysis. The relative quantification of gene expression was analyzed by the 2 −ΔΔCt method.
Extraction of nuclear proteins
Nuclear protein extracts were obtained as previously described [3] . In brief, cells were pretreated with CucE (1 μM) for 30 min, and then exposed to PDB (0.5 μM) + Ion (0.5 μg/ml) in a humidified incubator with 5% CO 2 for 0, 30, 60, and 120 min, respectively. Then, cells were treated with the lysis buffer (50 mM Tris, pH 7.4, 1% NP-40, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, and 1 μg/ml each of aprotinin, leupeptin, and pepstatin, from Roche) to remove cytosolic proteins. After being washed once more with the lysis buffer, nuclear proteins were scraped from the dishes in 2× SDS-PAGE loading buffer. Lysates were sonicated, boiled, and clarified by centrifugation at 12,000 g for 20 min at 4°C. Protein concentration was measured by SDS-PAGE with a known sample determined by a BCA protein assay kit (Pierce, Rockford, USA) according to the manufacturer's instructions.
Western blot analysis
Western blotting was performed as described previously [18] . In brief, whole cell lysates were obtained from Jurkat T cells stimulated with PDB (0.5 μM) + Ion (0.5 μg/ml) with or without the pretreatment of CucE (1 μM) for 30 min. Immunoblotting was performed using antibodies against p-RelA/p65(S536), p65, p-IκBα(S32), p-JNK(T183/ Y185), c-Jun N-terminal kinase (JNK), p-Erk1/2(T202/Y204), Erk1/ 2, p-p38MAPK(T180/Y182), p38MAPK, β-tubulin, and lamin A/C. The densitometry of each band was quantified by FluorChem 8000 (AlphaInnotech, San Leandro, USA).
Immunofluorescence microscopy
Immunofluorescence analysis was performed essentially as previously described [2] . Cells were fixed in 4% paraformaldehyde, permeabilized with ice-cold 100% methanol, and immunostained with rabbit anti-p65 antibody followed by CF568-conjugated goat-anti-rabbit IgG, highly cross-absorbed (Biotium, Hayward, USA 
Statistical analysis
All experiments were performed in triplicate, with one representative of three separated experiments shown. Data were expressed as mean ± SD. Statistical analysis was performed using Graphpad Prism 5.0 (GraphPad Software Inc., San Diego, USA). One-way ANOVA, followed by Newman-Keuls multiple comparison tests, was used to analyze the statistical significance among multiple groups. A P value of <0.05 was considered statistically significant.
Results
The cytotoxicity of CucE on Jurkat T cells
The cytotoxicity of CucE on Jurkat T cells was initially assessed using a modified 3-4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (WST-1). As shown in Fig. 1A , there was no significant acute cytotoxicity of CucE within 6 h incubation when its concentration was 1 μM or less in unstimulated cells. When the incubation time was prolonged to 24 h, the cytotoxic effect of CucE was <40% when its concentration was 1 μM or less, suggesting a limited cytotoxicity of this drug when used at low concentration. Furthermore, CucE's cytotoxicity was also measured in cells stimulated with PDB and Ion. As shown in Fig. 1B (left) , CucE displayed lowered acute cytotoxicity on Jurkat T cells treated with PDB + Ion compared with that of unstimulated cells. Similarly, after 24 h incubation, the cytotoxicity of CucE was also reduced in PDB + Ion-stimulated cells, with CucE of 1 μM or less being non-cytotoxic (Fig. 1B, right) . One possible explanation for this lowered cytotoxicity of CucE on cells stimulated with PDB plus Ion might be due to increased expression of anti-apoptotic proteins in cells treated with phorbol ester and calcium ionophore [19, 20] , which needs additional investigation. Thus, our data indicated that CucE had no significant cytotoxicity on PDB + Ion-stimulated Jurkat T cells when its concentration was 1 μM or less; thus, three doses (0.1, 0.3, and 1 μM) without cytotoxicity were adopted for the subsequent experiments.
CucE inhibited the secretion of IL-2, TNF-α, and IFN-γ by activated Jurkat T cells Activated T cells secret several critical cytokines, including IL-2, TNF-α, and IFN-γ, which play important roles in both the innate and adaptive immune responses. We examined the effect of CucE on cytokine secretion in culture medium of Jurkat T cells stimulated with PDB and Ion. Cytometric bead assay showed that PDB plus Ion stimulation induced high levels of IL-2 and IFN-γ in culture medium while CucE alone had no significant effect on cytokine expression ( Fig. 2A,B) . The change of TNF-α level was only detectable after stimulation with PDB + Ion for 24 h. Interestingly, CucE dose-dependently inhibited the production of all these cytokines. Considering the critical roles of such cytokines in executing T cell functions, this result suggested that CucE might attenuate the adaptive immune responses of T cells. and IFN-γ (both 3 and 6 h), respectively (Fig. 3A,B) . These results suggested that CucE suppressed IL-2, TNF-α, and IFN-γ protein expression by decreasing their mRNA levels.
CucE modulated NF-κB and MAPK signaling
It is well known that both the NF-κB and MAPK pathways are crucial in modulating the transcription of numerous immune-related genes including IL-2, TNF-α, and IFN-γ. As it reduced the mRNA levels of IL-2, TNF-α, and IFN-γ, we tested whether CucE influenced the NF-κB and MAPK signaling in activated Jurkat T cells. Western blot analysis showed that PDB plus Ion stimulation increased the phosphorylation levels of IκB and NF-κB/p65, whereas CucE treatment significantly decreased the phosphorylation levels of IκB and p65 (Fig. 4A,B) . As decreased phosphorylation of NF-κB/p65 may prevent its entrance into the nucleus, we thus examined whether CucE could influence the nuclear accumulation of NF-κB/p65 by assessing its nuclear levels using western blot assay. PDB + Ion stimulation induced a rapid nuclear accumulation in Jurkat T cells. CucE significantly decreased the levels of NF-κB/p65 in the nucleus at the time point of 120 min, albeit not at the early time points (Fig. 4C,D) , suggesting that it might suppress NF-κB/p65 nuclear translocation at later time points.
To further confirm CucE's effect on NF-κB/p65 nuclear translocation, immunofluorescence microscopy was used to examine the distribution of NF-κB/p65 in Jurkat T cells. NF-κB/p65 was mostly distributed in the cytosol of unstimulated cells; PDB + Ion stimulation caused a redistribution of NF-κB/p65 into the nucleus. Consistent with the result of western blotting, CucE treatment suppressed the nuclear translocation of NF-κB/p65 in PDB + Ion-stimulated cells (Fig. 4E) . All these results indicated that CucE attenuated PDB + Ion-induced NF-κB signaling by down-regulating its phosphorylation levels and suppressing its nuclear translocation.
As expected, the phosphorylation levels of JNK, Erk1/2, and p38MAPK were rapidly increased after PDB + Ion stimulation. Of note, the p-JNK and p-p38MAPK were decreased sharply after 30 min incubation, probably due to a negative feedback signaling in response to robustly pharmacological stimulation. In contrast to its effect on the NF-κB signaling, CucE had no inhibitory effect on the phosphorylation Figure 4 . Inhibitory effect of CucE on the NF-κB signaling (A) Cells were pretreated with CucE (1 μM) for 30 min, and then exposed to PDB (0.5 μM) + Ion (0.5 μg/ml) for 0, 15, 30, and 60 min, respectively. The protein levels were determined by western blotting. β-Tubulin was used as a loading control. The relative densitometric ratios of each protein to β-tubulin are shown in (B). (C) Cells were pretreated with CucE (1 μM) for 30 min, and then exposed to PDB (0.5 μM) + Ion (0.5 μg/ml) for 0, 30, 60, and 120 min, respectively. The nuclear protein levels were determined by western blotting. Lamin A/C was used as a loading control for nuclear lysates. The relative densitometric ratios of each protein to lamin A/C are shown in (D). Values are shown as the mean ± SD of three experiments.
## P < 0.01; *P < 0.05 and **P < 0.01. N.S., not significant. (E) Jurkat T cells were pretreated with CucE (1 μM) or left untreated for 30 min, and then exposed to PDB (0.5 μM) + Ion (0.5 μg/ml) for 120 min. Immunofluorescence microscopy was used to reveal the distribution of NF-κB/p65 (red) in cells. Nuclei (blue) were revealed by Hoechst33342 staining. Representative of at least 10 images for each group is shown. Scale bars, 10 μm.
levels of MAPKs or slightly enhanced their phosphorylation at some time points (Fig. 5A,B) . These results indicated that CucE had minimal effect on the MAKP signaling induced by PDB + Ion stimulation.
Discussion
T cells play a central role in both innate and adaptive immune responses. Their functions rely on the complete activation and cytokine production, all of which have been targeted by anti-inflammatory or immunosuppressive agents [16, 17] . In this study, we used Jurkat T cells as a cellular model to evaluate the anti-inflammatory effect of CucE and found that CucE could significantly inhibit the secretion of IL-2, TNF-α, and IFN-γ in activated Jurkat T cells. The mRNA levels of these cytokines were also markedly reduced upon CucE treatment, which might be due to the down-regulation of NF-κB signaling in CucE-treated cells. Our data suggest a potential link between the suppression of cytokine expression and the immunosuppressive effect of CucE.
The cytokines, including IL-2, TNF-α, and IFN-γ, have central roles for T cells in executing their functions. As a pleiotropic cytokine, IL-2 acts through its high-affinity IL-2R to increase the proliferation and differentiation of T cells and B cells [21] [22] [23] . Pro-inflammatory cytokine TNF-α can augment inflammatory responses by acting on many immune and non-immune cells as well as by stimulating the secretion of other pro-inflammatory cytokines [24, 25] . Besides, IFN-γ can promote both the innate and adaptive immune responses against tumor cells and a variety of infectious agents [26, 27] ; it is also critical in the development of inflammatory diseases [27] . Therefore, by attenuating the expression of these critical cytokines, CucE may suppress adaptive immune responses mediated by T cells, thereby dampening ongoing inflammatory responses and contributing to its therapeutic activity in controlling inflammatory diseases.
Concomitant with the attenuation of cytokines, we observed in this study that CucE suppressed the phosphorylation of IκB and NF-κB/p65 as well as diminishing nuclear translocation of NF-κB/ p65 in Jurkat T cells. As NF-κB is the crucial transcription factor involved in inflammatory responses as well as in the production of cytokines by T cells [28] , we proposed that CucE-induced suppression of cytokine expression may be mediated by down-regulating the NF-κB signaling. In support of this notion, the mRNA levels of the NF-κB target genes, IL-2, TNF-α, and IFN-γ, were markedly reduced upon CucE treatment. Our observation was consistent with previous studies that CucE suppressed the production of TNF-α and IL-1β in mouse RAW264.7 cells and that cucurbitacin IIb decreased the mRNA levels of IκBα (also an NF-κB target gene) and TNF-α in mouse lymphocytes [2, 3] . Importantly, all these studies together with our data indicated that NF-κB/p65 nuclear translocation was attenuated by cucurbitacins. However, previous studies showed that CucE did not reduce the phosphorylation levels of both IκBα and NF-κB/p65 but blocked NF-κB/p65 nuclear translocation in RAW264.7 cells [3] . Similar observation was reported in mouse lymphocytes treated with cucurbitacin IIb [2] . This discrepancy between the present study and previous studies may arise from the fact that human cells were used in this study, whereas cells of mouse origin were adopted in previous studies [2, 3] . Notably, in agreement with previous observations [2, 3] , CucE had no significant suppression on MAPK signaling but rather slightly enhanced the signaling of MAPKs probably due to the robust stresses induced by CucE applied to cells. Taken together, our results revealed that CucE significantly inhibited the expression of IL-2, TNF-α, and IFN-γ by down-regulating the NF-κB signaling, highlighting its application as a promising agent in treating inflammatory diseases.
In conclusion, our data demonstrated that CucE could suppress cytokine expression likely via down-regulating the NF-κB signaling, thus dampening the adaptive immune response during inflammation Figure 5 . Effect of CucE on the MAPK signaling (A) Cells were pretreated with CucE (1 μM) for 30 min, and then exposed to PDB (0.5 μM) + Ion (0.5 μg/ml) for 0, 15, 30, and 60 min, respectively. The protein levels were determined by western blotting. β-Tubulin was used as a loading control. The relative densitometric ratios of each protein to β-tubulin are shown in (B). Values are shown as the mean ± SD of three experiments.
## P < 0.01; *P < 0.05 and **P < 0.01. N.S., not significant.
or pathological inflammatory responses. Further research into the in vivo action mechanism of CucE is needed to validate our in vitro data.
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